SINGAPORE - Israeli firm Trendlines Group announced on Tuesday that all the shares in its initial public offering (IPO) have all been "fully subscribed" to.
The company, which incubates early-stage life sciences companies in the medical and agricultural fields, said in a filing to the Singapore Exchange that it has received 286 applications for the public offer, which represented some 75.8 million offer shares for 33 Singapore cents each.
About S$25 million was raised by the close of the IPO at noon.
The shares are expected to commence trading on the Catalist board on Nov 26.
